Corinne Faivre-Finn

Professor Corinne Faivre-Finn is a Professor of Thoracic Radiation Oncology at the University of Manchester and an Honorary Consultant Clinical Oncologist at The Christie NHS Foundation Trust. She is internationally recognized for her leadership in clinical trials and radiotherapy research for lung cancer.

• Education:
  • PhD in 'Improvement of Care Practices and Prognosis of Colorectal Cancer. Population Studies'
  • MSc in Epidemiology and Clinical Research
  • MSc in Cancer Chemotherapy and Pharmacology
  • MSc in Pharmacology

Her research spans phase I-III clinical trials combining novel drugs (e.g., DNA damage repair inhibitors) with radiotherapy, platform and pragmatic trial methodologies, and digital health innovations to address disparities in cancer care. She pioneered the RAPID-RT NIHR programme to integrate Learning Healthcare System principles into radiotherapy practice.

Recent publications highlight her work in radiation-related cardiotoxicity, targeted therapy combinations, and genetic risk factors for radiation toxicity. Her trials (e.g., PACIFIC, LungART) have altered global treatment standards.

Scientific Awards:

• Christie International Researcher of the Year (2016)
• IASLC Jim Cox Lectureship (2019)
• ESTRO Honorary Physicist (2022)
• Greater Manchester Cancer Innovation Award (2022)
• NIHR Senior Investigator (2023)

She supervises MRes, MD, and PhD fellows and collaborates with multidisciplinary teams across the UK and internationally (e.g., Gustave Roussy, Maastricht). Her work aligns with UN Sustainable Development Goals in health equity and innovation.